J&J MedTech restarts Varipulse's US rollout after stroke reports
J&J said it found no immediate procedure-related causes from the atrial fibrillation therapy but that risks can escalate if a high number of consecutive ablations are delivered.
J&J said it found no immediate procedure-related causes from the atrial fibrillation therapy but that risks can escalate if a high number of consecutive ablations are delivered.
